Envacgen (inactivated EV71 vaccine)
/ Medigen Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 29, 2024
Long-Term Immunogenicity Study of an Aluminum Phosphate-Adjuvanted Inactivated Enterovirus A71 Vaccine in Children: An Extension to a Phase 2 Study.
(PubMed, Vaccines (Basel))
- "No long-term safety issues were reported. Our study provides novel insights into the long-term immunity conferred by EV71vac in children aged from two months to six years, particularly in those who received EV71vac between two and six months of age."
Journal • P2 data • CNS Disorders • Pediatrics
1 to 1
Of
1
Go to page
1